Wright AA et al., 2014-03-04: Prospective cohort of 386 terminally ill cancer patients at eight US clinics. Patients on palliative chemotherapy were more likely to die in an ICU (11% v 2%) and less likely to die at home (47% v 66%), with no survival difference (HR 1.11).
Patients receiving palliative chemotherapy were more likely to die in an intensive care unit (11% v 2%; adjusted risk difference 6.1%, 1.1% to 11.1%) and less likely to die at home (47% v 66%; -10.8%, -1.0% to -20.6%), compared with those who were not.
p.g1219 (Abstract, Results)
Wright AA et al., 2014-03-04: Prospective cohort of 386 terminally ill cancer patients at eight US clinics. Patients on palliative chemotherapy were more likely to die in an ICU (11% v 2%) and less likely to die at home (47% v 66%), with no survival difference (HR 1.11). Competing-interests statement in the record: all authors completed ICMJE forms; HGP reports research grants from NIMH and NCI, AAW reports research grants (statement truncated in the record). No industry drug maker; observational. Comparator: no palliative chemotherapy, propensity-score weighted. Same multicentre cohort family as CHD-10. Study type: controlled study.
